We bring you the latest news from the healthcare about the health care in the United Kingdom.

woensdag 24 januari 2018

British Journal of Cancer - Table of Contents alert Volume 118 Issue 2

If you are unable to see the message below, click here to view.
British Journal of Cancer
TABLE OF CONTENTS

Volume 118, Issue 2 (145-307)
Published online 23 January 2018
 

In this issue
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Corrigenda
Errata

Also new today
Advance online publication
Digital Edition
 
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Review

Top

How the evolution of multicellularity set the stage for cancer

Anna S Trigos, Richard B Pearson, Anthony T Papenfuss and David L Goode

Br J Cancer 2018 118: 145-152; advance online publication, January 16, 2018; 10.1038/bjc.2017.398

Abstract | Full Text

Clinical Studies

Top

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours

Jeffrey R Infante, Ronald L Korn, Lee S Rosen, Patricia LoRusso, Samuel S Dychter, Joy Zhu, Daniel C Maneval, Ping Jiang, H Michael Shepard, Gregory Frost, Daniel D Von Hoff, Mitesh J Borad and Ramesh K Ramanathan

Br J Cancer 2018 118: 153-161; advance online publication, September 26, 2017; 10.1038/bjc.2017.327

Abstract | Full Text

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

Leigh G Seamon, James J Java, Bradley J Monk, Richard T Penson, Jubilee Brown, Robert S Mannel, Anna Oaknin, Mario M Leitao, Eric L Eisenhauer, Harry J Long, Shu Y Liao and Krishnansu S Tewari

Br J Cancer 2018 118: 162-170; advance online publication, November 28, 2017; 10.1038/bjc.2017.400

Abstract | Full Text

Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma

Yuki Kitano, Hirohisa Okabe, Yo-ichi Yamashita, Shigeki Nakagawa, Yoichi Saito, Naoki Umezaki, Masayo Tsukamoto, Takanobu Yamao, Kensuke Yamamura, Kota Arima, Takayoshi Kaida, Tatsunori Miyata, Kosuke Mima, Katsunori Imai, Daisuke Hashimoto, Yoshihiro Komohara, Akira Chikamoto, Takatoshi Ishiko and Hideo Baba

Br J Cancer 2018 118: 171-180; advance online publication, November 9, 2017; 10.1038/bjc.2017.401

Abstract | Full Text

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response

Angela Lamarca, Jorge Barriuso, Matthew Kulke, Ivan Borbath, Heinz-Josef Lenz, Jean Luc Raoul, Neal J Meropol, Catherine Lombard-Bohas, James Posey, Sandrine Faivre, Eric Raymond and Juan W Valle

Br J Cancer 2018 118: 181-188; advance online publication, November 21, 2017; 10.1038/bjc.2017.402

Abstract | Full Text

Translational Therapeutics

Top

Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation

Amanda R Noble, Norman J Maitland, Daniel M Berney and Martin G Rumsby

Br J Cancer 2018 118: 189-199; advance online publication, November 14, 2017; 10.1038/bjc.2017.391

Abstract | Full Text

The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells

Serena Pillozzi, Massimo D'Amico, Gianluca Bartoli, Luca Gasparoli, Giulia Petroni, Olivia Crociani, Tiziano Marzo, Angela Guerriero, Luigi Messori, Mirko Severi, Roberto Udisti, Heike Wulff, K George Chandy, Andrea Becchetti and Annarosa Arcangeli

Br J Cancer 2018 118: 200-212; advance online publication, November 21, 2017; 10.1038/bjc.2017.392

Abstract | Full Text

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression

Eiji Kashiwagi, Satoshi Inoue, Taichi Mizushima, Jinbo Chen, Hiroki Ide, Takashi Kawahara, Leonardo O Reis, Alexander S Baras, George J Netto and Hiroshi Miyamoto

Br J Cancer 2018 118: 213-223; advance online publication, November 9, 2017; 10.1038/bjc.2017.393

Abstract | Full Text

Molecular Diagnostics

Top

ALDH1A3 affects colon cancer in vitro proliferation and invasion depending on CXCR4 status

Hailiang Feng, Yanyan Liu, Xiaocui Bian, Fangying Zhou and Yuqin Liu

Br J Cancer 2018 118: 224-232; advance online publication, December 12, 2017; 10.1038/bjc.2017.363

Abstract | Full Text

BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM

Fang Wei, Yingfen Wu, Le Tang, Yi He, Lei Shi, Fang Xiong, Zhaojian Gong, Can Guo, Xiayu Li, Qianjin Liao, Wenling Zhang, Ming Zhou, Bo Xiang, Xiaoling Li, Yong Li, Guiyuan Li, Wei Xiong and Zhaoyang Zeng

Br J Cancer 2018 118: 233-247; advance online publication, November 9, 2017; 10.1038/bjc.2017.385

Abstract | Full Text

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?

Jane Margetts, Laura F Ogle, Stephen L Chan, Anthony W H Chan, K C Allen Chan, David Jamieson, Catherine E Willoughby, Derek A Mann, Caroline L Wilson, Derek M Manas, Winnie Yeo and Helen L Reeves

Br J Cancer 2018 118: 248-257; advance online publication, November 9, 2017; 10.1038/bjc.2017.386

Abstract | Full Text

MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer

Madeleine L Craze, Hayley Cheung, Natasha Jewa, Nuno D M Coimbra, Daniele Soria, Rokaya El-Ansari, Mohammed A Aleskandarany, Kiu Wai Cheng, Maria Diez-Rodriguez, Christopher C Nolan, Ian O Ellis, Emad A Rakha and Andrew R Green

Br J Cancer 2018 118: 258-265; advance online publication, November 23, 2017; 10.1038/bjc.2017.387

Abstract | Full Text

Genetics & Genomics

Top

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Christos Mikropoulos, Christina G Hutten Selkirk, Sibel Saya, Elizabeth Bancroft, Emily Vertosick, Tokhir Dadaev, Charles Brendler, Elizabeth Page, Alexander Dias, D Gareth Evans, Jeanette Rothwell, Lovise Maehle, Karol Axcrona, Kate Richardson, Diana Eccles, Thomas Jensen, Palle J Osther, Christi J van Asperen, Hans Vasen, Lambertus A Kiemeney, Janneke Ringelberg, Cezary Cybulski, Dominika Wokolorczyk, Rachel Hart, Wayne Glover, Jimmy Lam, Louise Taylor, Monica Salinas, Lidia Feliubadal√≥, Rogier Oldenburg, Ruben Cremers, Gerald Verhaegh, Wendy A van Zelst-Stams, Jan C Oosterwijk, Jackie Cook, Derek J Rosario, Saundra S Buys, Tom Conner, Susan Domchek, Jacquelyn Powers, Margreet GEM Ausems, Manuel R Teixeira, Sofia Maia, Louise Izatt, Rita Schmutzler, Kerstin Rhiem, William D Foulkes, Talia Boshari, Rosemarie Davidson, Marielle Ruijs, Apollonia TJM Helderman-van den Enden, Lesley Andrews, Lisa Walker, Katie Snape, Alex Henderson, Irene Jobson, Geoffrey J Lindeman, Annelie Liljegren, Marion Harris, Muriel A Adank, Judy Kirk, Amy Taylor, Rachel Susman, Rakefet Chen-Shtoyerman, Nicholas Pachter, Allan Spigelman, Lucy Side, Janez Zgajnar, Josefina Mora, Carole Brewer, Neus Gadea, Angela F Brady, David Gallagher, Theo van Os, Alan Donaldson, Vigdis Stefansdottir, Julian Barwell, Paul A James, Declan Murphy, Eitan Friedman, Nicola Nicolai, Lynn Greenhalgh, Elias Obeid, Vedang Murthy, Lucia Copakova, John McGrath, Soo-Hwang Teo, Sara Strom, Karin Kast, Daniel A Leongamornlert, Anthony Chamberlain, Jenny Pope, Anna C Newlin, Neil Aaronson, Audrey Ardern-Jones, Chris Bangma, Elena Castro, David Dearnaley, Jorunn Eyfjord, Alison Falconer, Christopher S Foster, Henrik Gronberg, Freddie C Hamdy, Oskar Johannsson, Vincent Khoo, Jan Lubinski, Eli Marie Grindedal, Joanne McKinley, Kylie Shackleton, Anita V Mitra, Clare Moynihan, Gad Rennert, Mohnish Suri, Karen Tricker, The IMPACT study collaborators91, Sue Moss, Zsofia Kote-Jarai, Andrew Vickers, Hans Lilja, Brian T Helfand and Rosalind A Eeles

Br J Cancer 2018 118: 266-276; advance online publication, January 4, 2018; 10.1038/bjc.2017.429

Abstract | Full Text

MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours

Diego A Garcia-Dios, Dina Levi, Vandna Shah, Cheryl Gillett, Michael A Simpson, Andrew Hanby, Ian Tomlinson and Elinor J Sawyer

Br J Cancer 2018 118: 277-284; advance online publication, January 9, 2018; 10.1038/bjc.2017.450

Abstract | Full Text

Epidemiology

Top

Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model

Jennifer Anne Cooper, Nick Parsons, Chris Stinton, Christopher Mathews, Steve Smith, Stephen P Halloran, Sue Moss and Sian Taylor-Phillips

Br J Cancer 2018 118: 285-293; advance online publication, November 2, 2017; 10.1038/bjc.2017.375

Abstract | Full Text

Tetracycline use and risk of incident skin cancer: a prospective study

Wen-Qing Li, Aaron M Drucker, Eunyoung Cho, Francine Laden, Trang VoPham, Suyun Li, Martin A Weinstock and Abrar A Qureshi

Br J Cancer 2018 118: 294-298; advance online publication, October 26, 2017; 10.1038/bjc.2017.378

Abstract | Full Text

The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort

Daisuke Kawakita, Yuan-Chin Amy Lee, Lisa H Gren, Saundra S Buys, Carlo La Vecchia and Mia Hashibe

Br J Cancer 2018 118: 299-306; advance online publication, November 21, 2017; 10.1038/bjc.2017.383

Abstract | Full Text

Corrigenda

Top

No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy

Alexandra K Walker, Christiana Kartsonaki, Elena Collantes, Judith Nicholson, Duncan C Gilbert and Anne E Kiltie

Br J Cancer 2018 118: e1; advance online publication, January 11, 2018; 10.1038/bjc.2017.410

Full Text

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

Rachna T Shroff, Mark Yarchoan, Ashley O'Connor, Denise Gallagher, Marianna L Zahurak, Gary Rosner, Chimela Ohaji, Susan Sartorius-Mergenthaler, Rose Parkinson, Vivek Subbiah, Ralph Zinner and Nilofer S Azad

Br J Cancer 2018 118: e2; advance online publication, January 9, 2018; 10.1038/bjc.2017.418

Full Text

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours

Jeffrey R Infante, Ronald L Korn, Lee S Rosen, Patricia LoRusso, Samuel S Dychter, Joy Zhu, Daniel C Maneval, Ping Jiang, H Michael Shepard, Gregory Frost, Daniel D Von Hoff, Mitesh J Borad and Ramesh K Ramanathan

Br J Cancer 2018 118: e3; 10.1038/bjc.2017.438

Full Text

Errata

Top

Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

Stephanie A Schubert, Dina Ruano, Fadwa A Elsayed, Arnoud Boot, Stijn Crobach, Arantza Farina Sarasqueta, Bruce Wolffenbuttel, Melanie M van der Klauw, Jan Oosting, Carli M Tops, Ronald van Eijk, Hans FA Vasen, Rolf HAM Vossen, Maartje Nielsen, Sergi Castellv√≠-Bel, Clara Ruiz-Ponte, Ian Tomlinson, Malcolm G Dunlop, Pavel Vodicka, Juul T Wijnen, Frederik J Hes, Hans Morreau, Noel FCC de Miranda, Rolf H Sijmons and Tom van Wezel

Br J Cancer 2018 118: e4; advance online publication, October 12, 2017; 10.1038/bjc.2017.380

Full Text

HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer

Tristan A Barnes and Eitan Amir

Br J Cancer 2018 118: e5; advance online publication, January 9, 2018; 10.1038/bjc.2017.417

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature